The Impact of Picture Narrative Format on Print Lung Screening Communication Outcomes
The Impact of Picture Narrative Format on Knowledge and Acceptability for Lung Screening Print Decision Support Materials
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Population screening is key to detecting lung cancer early at a more treatable stage. Uptake of screening should be equitable (i.e., screening benefits all eligible members of the population and does not contribute further to health disparities) and informed (i.e., participants have been involved in the decision to take part and their decision aligns with their values and circumstances). Print decision support materials are the primary mechanism for encouraging engagement with cancer screening and supporting decision making. It is essential that we identify print communication techniques that are effective in informing invitees about lung screening.
The intervention, picture narrative information about lung screening, was previously developed through codesign and prototype testing with people likely to be eligible for lung screening (50 to 75 years old, past or current heavy smokers). Participants will be randomised to one of three groups: Picture narrative format, Text with pictures (control 1) or, Text-only (control 2). This study will assess whether presenting lung screening information in a picture narrative format can improve lung cancer screening knowledge, eligibility self-assessment and attitudes. It will also assess whether perceptions of the information designs can explain any impact of the intervention on these outcomes and whether there are differences across socioeconomic groups.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
-
Glasgow, Royaume-Uni, G12 0XH
- Mental Health and Wellbeing, University of Glasgow
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Living in Glasgow
- Willing and able to respond unaided to invitation to participate in the trial and give informed consent.
- Aged between 49 and 75 years
Exclusion Criteria:
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Recherche sur les services de santé
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Picture narrative lung screening information
Participants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format which uses text in combination with sequences of pictures to communicate a coherent message.
The designs follow conventions from comics/graphic narratives and key stakeholders were involved during the design process.
|
Lung screening information formatted as picture narratives
|
|
Comparateur actif: Text with pictures lung screening information
Participants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format that uses text with non-narrative pictures for decoration.
The pictures have been extracted from the picture narratives being used Arm 1.
|
Lung screening information formatted as text and non-narrative pictures
|
|
Comparateur actif: Text-only lung screening information
Participants in this arm receive information about lung screening purpose, eligibility, benefits and risks in a format that uses text and no pictures.
|
Lung screening information formatted as text with no pictures
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Participant Lung Cancer Screening Knowledge scores
Délai: Immediately post-intervention
|
Participants will be asked 6 multiple choice questions related to the lung screening information presented to the participants during the intervention, covering; Procedure, Eligibility - who, Eligibility - why, Benefits, Adverse effects, Potential results.
|
Immediately post-intervention
|
|
Lung Cancer Screening Eligibility self-assessment
Délai: Immediately post-intervention
|
Concordance between self-reported personal eligibility for lung cancer screening and actual eligibility based on self-reported age and smoking behaviour.
|
Immediately post-intervention
|
|
Participant Lung Cancer Screening Attitudes
Délai: Immediately post-intervention
|
Self-administered four-item lung cancer screening attitudes measure covering cancer fear, fatalism, benefits, and worry, previously used by Smits et al 2018.
|
Immediately post-intervention
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Participant Design appraisal ratings
Délai: Immediately post-intervention
|
Self-administered nine-item measure rating perceptions of appeal, enjoyment, interest, ease of use, trustworthiness, appropriateness, helpfulness, informativity. Alongside a single item asking participants whether enough information was provided. |
Immediately post-intervention
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Treatment compliance
Délai: Immediately post-intervention
|
Self-reported length of time spent reading the lung screening information.
|
Immediately post-intervention
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Kathryn Robb, PhD, University of Glasgow
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 200200021
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Délai de partage IPD
Critères d'accès au partage IPD
Type d'informations de prise en charge du partage d'IPD
- PROTOCOLE D'ÉTUDE
- CIF
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .